50 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28324649	99	Sulfonamides as Selective Na	Amgen
28287723	73	Sulfonamides as Selective Na	Amgen
27994738	50	Sulfonamides as Selective Na	Amgen
26985315	49	Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models.	Xenon Pharmaceuticals
25927480	36	Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.	Merck Research Laboratories
24601592	48	Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.	University College London
23121096	86	Ion channels as therapeutic targets: a drug discovery perspective.	Pfizer
22981330	7	Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry.	Universit£
21962108	14	Lactam-stabilized helical analogues of the analgesicµ-conotoxin KIIIA.	Monash University
19341281	32	Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones.	University College London
32392056	108	Discovery of DS-1971a, a Potent, Selective Na	Daiichi Sankyo
27441383	117	Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.	Amgen
30943032	31	Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na	Genentech
30538065	48	The discovery and optimization of benzimidazoles as selective Na	Pfizer
31012583	128	Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na	Siteone Therapeutics
27015369	78	Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.	Abbvie
29737846	70	Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa	Xenon Pharmaceuticals
28988749	7	Peptide therapeutics from venom: Current status and potential.	Peptides International
29439904	91	Discovery of morpholine-based aryl sulfonamides as Na	Bristol-Myers Squibb Research and Development
29029933	45	Highly potent and selective Na	Pfizer
30346167	71	Discovery of Tarantula Venom-Derived Na	Amgen
28682065	133	Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na	Icagen